Last updated on June 2019

A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

Brief description of study

The purpose of this study is to determine whether nivolumab plus ipilimumab or nivolumab alone is effective and safe in the treatment of solid tumors with High Tumor Mutational Burden (TMB-H)

Clinical Study Identifier: NCT03668119

Find a site near you

Start Over

Fundacion De Investigacion

San Juan, Puerto Rico
  Connect »